Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 3: Adjusted primary outcomes for patients with AIS with versus patients without EVT procedural complications
Clinical Outcome AIS with Procedural Complications(n = 113) AIS without Procedural Complications(n = 571) Adjusted OR or β Coefficient (95% CI) Adjusted P Value
Short-term clinical consequences (24-hour Δ-NIHSS) –2.21 (10.06) –4.33 (7.89) 2.73 (1.09–4.37) <.001^{^a}
Long-term functional outcome at 3 months (mRS) (median) (IQR) 3 (2–5) 2 (1–4) 1.32 (0.81–2.16) .272
↵a Significant.

Clinical Outcome	AIS with Procedural Complications(n = 113)	AIS without Procedural Complications(n = 571)	Adjusted OR or β Coefficient (95% CI)	Adjusted P Value
Short-term clinical consequences (24-hour Δ-NIHSS)	–2.21 (10.06)	–4.33 (7.89)	2.73 (1.09–4.37)	<.001^{^a}
Long-term functional outcome at 3 months (mRS) (median) (IQR)	3 (2–5)	2 (1–4)	1.32 (0.81–2.16)	.272